| 2014-06-01 | Small Project Funding - “Study of alternative splicing of esophageal squamous cell carcinoma through transcriptome analysis in Hong Kong” HK$46,327: University Research Committee
| Research Achievement
|
| 2014-05-01 | Advanced Study Institute: Croucher Foundation
| Research Achievement
|
| 2014-06-01 | Research Grant 2013-2015 - “Genomic studies of esophageal squamous cell carcinoma familial genetic susceptibility and diagnostic biomarkers” HK$800,000: Asian Cancer Research Fund
| Research Achievement
|
| 2014-05-01 | Advances in Nasopharyngeal Carcinoma Studies: Croucher Foundation Advanced Study Institute
| Research Achievement
|
| 2014-06-01 | Research Grant 2013-2015 - “The SAA1 polymorphism vs risk factors in ESCC” $785,624 (Co-investigator): Health Medical Research Fund
| Research Achievement
|
| 2010-06-01 | Molecular genetics and clinical advances in the study of esophageal and gastric cancers: Advanced Studies Institute: Croucher Foundation
| Research Achievement
|
| 2014-06-01 | Research Grant 2014-2015 - “Genomic studies of esophageal squamous cell carcinoma familial genetic susceptibility and diagnostic biomarkers” HK$345,000: Asian Cancer Research Fund
| Research Achievement
|
| 2014-06-01 | Research Grant 2013-2015 - “Elucidating the genetic basis for early-age onset NPC in Hong Kong” $1,000,000: Health Medical Research Fund
| Research Achievement
|
| 2014-06-01 | GRF Research Grant 2014 - "Secretory NID2, a basement membrane protein facilitating cell adhesion, migration, and metastasis in human cancers" HK$1,122,210: Research Grants Council
| Research Achievement
|
| 2005-03-01 | Croucher Senior Research Fellowship: Croucher Foundation
| Research Achievement
|
| 2014-06-01 | Research Grant 2013-2015 - “Genetic studies of NPC” $2,155,000: Hong Kong Cancer Fund
| Research Achievement
|
| 1992-01-01 | American Academy of Microbiology: American Academy of Microbiology
| Research Achievement
|
| 2014-02-01 | Seed Funding Programme for Basic Research - “Establishment of human nasopharyngeal carcinoma in 3D invasion and angiogenesis organotypic culture to study hypoxia-induced tumor invasion and angiogenesis” HK$47,900
| Research Achievement
|
| 2015-02-01 | Small Project Funding - “Functional validation of a novel DUB3 somatic mutation in tumors of NPC” HK$80,000: HKU University Research Committee
| Research Achievement
|
| 2015-05-01 | Advanced Studies Institute: Croucher Foundation
| Research Achievement
|
| 2015-02-01 | (Co-I), Research Grant 2015-2017 - “The effects of IKKbeta-specific inhibitor PS1145 on tumor formation and metastasis in NPC” HK$1,000,000: Health Medical Research Fund
| Research Achievement
|
| 2014-12-01 | OncoSeek Dec 2014-Mar 2015, HK$650,000: Technology Start-up Support Scheme for Universities
| Research Achievement
|
| 2015-06-01 | Gordon Research Conference, NPC Research Conference, $19,125 USD (2016, alternative years)
| Research Achievement
|
| 2015-06-01 | OncoSeek 2015-2017, HK$860,000: Hong Kong Science Park Incubator program
| Research Achievement
|
| 2015-02-01 | (Co-I), Research Grant 2015-2017 - “The clinical relevance of telomere attrition and NPC genetic susceptibility” HK$997,845: Health Medical Research Fund
| Research Achievement
|
| 2015-04-01 | OncoSeek April 2015-Mar 2016, HK$300,000: Technology Start-up Support Scheme for Universities
| Research Achievement
|
| 2015-11-01 | Corporate Sponsor: Lee’s Pharmaceutical (HK) Ltd. 2015-2017 - “Regulation and clinical implication of PD-L1 expression in esophageal tumor cells subjected to chemotherapy” HK$2,598,540: Innovation and Technology Commission
| Research Achievement
|
| 2015-09-01 | GRF Research Grant (Competitive Earmarked Research Grant) 2015-2018 - “Functional and mechanistic characterizations of a Candidate Tumor Suppressor Gene, Mirror Image Polydactyly 1, in Nasopharyngeal Carcinoma” HK$971,461 (Transferred from PI to Co-I, due to departure of PI): Research Grants Council
| Research Achievement
|
| 2016-06-01 | Research Grant 2016-2019 - “Targeted Genomics and Functional Studies of Novel Cancer Predisposing Genes for Esophageal Squamous Cell Carcinoma” HK$7,570,304: RGC Collaborative Research Fund
| Research Achievement
|
| 2015-09-01 | GRF Research Grant 2015-2017 - “Functional and mechanistic investigation of frequent p53 gain-of-function mutations in esophageal squamous cell carcinoma” HK$1,168,311: Research Grants Council
| Research Achievement
|
| 2014-06-01 | Small Project Funding - “Pilot Study for Deciphering Methylome of Nasopharyngeal Carcinoma (NPC)” HK$51,732: University Research Committee
| Research Achievement
|
| 2017-04-01 | (CO-I), Research grant, "Optimizing the selection of patients with metastatic colorectal cancer for liver resection - An immuno-clinical scoring system incorporating circulating tumor cell enumeration and clinical factors" HK$946,064: Health Medical Research Fund
| Research Achievement
|
| 2018-06-01 | Research grant, “Clinical application of enumeration and genomic characterization for non-invasive detection and real-time monitoring of circulating tumor cells for esophageal carcinoma” HK$1,199,732: Health Medical Research Fund
| Research Achievement
|
| 2018-01-01 | (Co-I), GRF Research Grant, “Genomic and functional study of rare deleterious germline mutations in candidate genes associated with familial risk for esophageal carcinoma” HK$971,720: Research Grants Council
| Research Achievement
|
| 2018-03-01 | “Non-invasive real-time monitoring and next-generation sequencing of circulating tumor cells for improved personalized treatment of metastatic colorectal cancer patients” HK$956,000: SK Yee Medical Foundation
| Research Achievement
|
| 2017-06-01 | "Establishing platform technology for use of circulating tumor cells for cancer diagnostics & drug testing" HK$1,000,000: Platform Technology Funding
| Research Achievement
|
| 2017-02-01 | "Centre for Nasopharyngeal Carcinoma Research" HK$707,783: FIL Foundation
| Research Achievement
|
| 2017-07-01 | “Translational Studies for Elucidation the Tumor Heterogeneity and Molecular Evolution in Metastatic Gastrointestinal Tract Cancers for Personalized Medicine” HK$33,333,000: Theme-based Research Scheme
| Research Achievement
|
| 2020-07-01 | (Co-I), Health and Medical Research Fund, "A Computational Framework Using Genomic and Transcriptomic Features for Predicting Resistance to PD-1/PDL-1 Checkpoint Inhibition in Gastrointestinal Tract (GIT) cancer", HK$851,952: Food and Health Bureau (FHB)
| Research Achievement
|
| 2020-07-01 | (Co-I), Health and Medical Research Fund, "Molecular classification based on microsatellite instability and RAS pathway status as prognostic biomarkers for risk stratification of metastatic relapse in colon carcinoma patients", HK$$1,499,750: Food and Health Bureau (FHB)
| Research Achievement
|
| 2015-02-01 | Small Project Funding - “Functional and mechanistic analysis of PHF11 in ESCC epigenetics” HK$42,256: HKU University Research Committee
| Research Achievement
|
| 2021-01-01 | (Co-I), "Clinical significance of real-time longitudinal monitoring of liquid biopsies for advanced colorectal cancer" 2021-2024: Health Medical Research Fund
| Research Achievement
|
| 2022-02-01 | (Co-I), “Understanding NPC Molecular Subtypes Associated with Clinical Outcome and Their Impact on Tumor Microenvironment” 2022-2025: Health Medical Research Fund
| Research Achievement
|
| 2022-01-01 | (Co-I), “Redefining resectability for colorectal liver metastasis: the role of circulating tumor cells and its molecular characteristics” 2022-2025: Health Medical Research Fund
| Research Achievement
|
| 2020-01-01 | (Co-I), GRF research grant, “Redefining resectability for colorectal liver metastasis: the role of circulating tumor cells and its molecular characteristics” HK$820,060: Research Grants Council
| Research Achievement
|
| 2019-01-01 | (Co-I), GRF research grant, “Genomic and functional study by targeting MST1R and its related chromosome 3p21.3 regions associated with genetic susceptibility in NPC” HK$956,853: Research Grants Council
| Research Achievement
|
| 2020-01-01 | (Co-I), GRF research grant, “An Epigenetic Landscape Study: Unraveling the Role of Loss of CCCTC-binding Factor CTCF in Epigenetic Dysregulation in Epstein-Barr Virus-positive Nasopharyngeal Carcinoma” HK$1,100,023: Research Grants Council
| Research Achievement
|
| 2019-06-01 | (Co-I), Research grant, “Establishment of a patient-derived organoid in vivo drug testing model in ESCC and a pilot study for tumor-associated macrophage targeted therapy” HK$1,484,832: Health Medical Research Fund
| Research Achievement
|